Skip to main content
. Author manuscript; available in PMC: 2009 Feb 24.
Published in final edited form as: Am J Physiol Renal Physiol. 2005 Sep 27;290(2):F273–F278. doi: 10.1152/ajprenal.00195.2005

Table 2.

Neurohumoral changes compared among groups

TLV vs. Pl Furo vs. Pl TLV vs. Furo
Arginine vasopressin, pg/ml P = 0.44 P = 0.51 P = 0.94
Plasma renin activity, ng·ml−1·h−1 P = 0.24 P = 0.02* P = 0.13
Aldosterone, ng/dl P = 0.20 P = 0.08 P = 0.10
Atrial natriuretic peptide, pg/ml P = 0.28 P = 0.11 P = 0.95
B-type natriuretic peptide, pg/ml P = 0.57 P = 0.36 P = 0.43
Norepinephrine, pg/ml P = 0.24 P = 0.005* P = 0.13

TLV, tolvaptan; Furo, furosemide; Pl, placebo.

*

Increase with Furo compared with Pl.

HHS Vulnerability Disclosure